Tanfac Industries Limited moves to reshape its capital structure

The 4,24,647 shares were allotted to four investors at Rs 2,341 per share:

The issue price is internally consistent: 4,24,647 shares × Rs 2,341 equals Rs 99,40,98,627, the total consideration reported by the company. The price comprises Rs 5 face value plus Rs 2,336 premium per share ^[1].

SEBI (ICDR) pricing alignment: the allotment disclosure states that the issue was made under Chapter V of the SEBI (ICDR) Regulations, but it does not report the relevant date, the applicable volume-weighted average price figures, or the resulting SEBI floor price ^[1]. Accordingly, the filing supports that the stated price was issued under the preferential-issue framework, but it does not provide enough numerical detail to independently verify whether Rs 2,341 was equal to or above the applicable VWAP-based minimum price.

The promoter received the largest allocation—2,60,065 shares—and its holding increased from 24.26% to 24.99%; the other three allottees had no pre-issue holding reported and received post-issue stakes of 0.46%, 0.25% and 0.05%, respectively ^[2].

The stated object of the issue is not debt repayment. The Rs 99.41 Crores preferential issue is earmarked for:

• Rs 75.55 Crores to finance the R-32 refrigerant-gas plant; and
• Rs 23.86 Crores for general corporate purposes,

with deployment planned during FY27. The issue proceeds are specifically stated not to be used to repay loans from the promoter or promoter group.^[3]

Balance-sheet and coverage impact

• Net debt: There is no direct reduction in gross borrowings because the stated use does not include loan repayment. If the full proceeds were received and temporarily retained as cash, net debt would mechanically decline by Rs 99.41 Crores, derived as opening net debt less the cash infusion. Once the proceeds are spent on the R-32 project or general corporate purposes, that cash benefit would reduce, unless the expenditure substitutes for incremental borrowing.
• Interest coverage: The infusion does not create an immediate mechanical improvement in interest coverage. Since no debt repayment is specified, interest expense should not fall at closing; the ratio would improve only if the project subsequently increases operating profit or if the proceeds prevent new debt from being raised.
• Quantification limit: The latest quarterly numerical data cited is Q4 FY26, when operating EBITDA was Rs 70 Crores and PAT was Rs 30 Crores.^[4] However, borrowings, interest expense and the company-reported interest-coverage ratio are not provided in the cited quarterly extract. Therefore, the post-infusion net-debt balance and interest-coverage ratio cannot be calculated reliably.

Analyst read: This is primarily a growth-capital infusion for the R-32 plant, not a balance-sheet deleveraging transaction. Its near-term effect is therefore liquidity support and avoidance of additional borrowing, while any improvement in net debt or interest coverage depends on how quickly the proceeds are deployed and the project begins generating earnings.

The allotment modestly shifts the promoter balance toward Anupam Rasayan, not Aditya Birla Group. The allottee disclosure identifies Anupam Rasayan India Limited—not Aditya Birla Group—as the promoter subscriber. Anupam received 2,60,065 shares, increasing its holding from 24.26% to 24.99%. TIDCO was not an allottee; its reported post-issue holding is 23.99%, while aggregate promoter holding is reported at 48.98%. ^{[1] [3]}

Governance impact: The issuance does not, based on the allotment disclosure, change the board composition or amend the Articles of Association. The securities issued are fully paid-up equity shares, and the filing does not state any change in director-nomination rights, board seats, or governance provisions. ^[1]

Voting impact: There is no disclosed change to the class of voting rights or to the Articles-defined voting framework. However, the new equity shares increase the total voting-share base. Accordingly, Anupam’s relative voting influence rises with its ownership from 24.26% to 24.99%, while existing non-subscribing shareholders are diluted proportionately. TIDCO receives no new shares and therefore does not gain additional votes from this issue. The allotment filing does not reproduce the relevant Articles provisions, so any partner-specific board nomination or veto rights cannot be independently verified from this disclosure.

The key distinction is therefore: economic and voting percentages change slightly; the contractual board-composition framework is not shown as changing.